1Mailer R H, Mader K, Gohla S. Solid lipid nanopartieles ( SLN ) for controlled drug delivery --a review of the state of the art[ J]. Eur J Pharm Biopharm ,2000,50 ( 1 ) : 161-177.
2Mehnert W, Madex K. Solid lipid nanoparticles : production, charac- terization and applications [ J ]. Adv Drug Deliv Rev, 2001,47 ( 2- 3 ): 165-!96.
3Ahlin P,Kfistl J, Sentjure M, et al. Influence of spin probe struc- ture on its distribution in SLN dispersions[ J]. Int J Pharm,2000, 196(2) :241-244.
4Muller R H ,Radtke M ,Wissing S A. Nanostructured lipid matrices for improved microencapsulation of drugs [ J ]. Int J Pharm,2002, 242(1-2) :121-128.
5Schafer-Korting M, Mehnert W, Korting H C. Lipid nanoparticles for improved topical application of drugs for skin diseases[ J]. Adv Drug Deliv Rev,2007,59(6) :427-443.
6Attama A A, Schicke B C,Paepenmuller T,et al. Solid lipid nano- dispersions containing mixed lipid core and a polar heterolipid: characterization [ J ]. Eur J Pharm Biopharm ,2007,67 ( 1 ) :48-57.
7Jenning V, Thunemann A F, Gohla S H. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids [ J ]. Int J Pharm ,2000,199 ( 2 ) : 167-177.
8Jenning V, Gohla S H. Encapsulation of retinoids in solid lipid nan- oparticles(SLN) [ J ]. J Microencapsul,2001,18 (2) : 149-158.
9Souto E B, Wissing S A, Barbosa C M, et al. Development of a con- trolled release formulation based on SLN and NLC for topical clot- rimazole delivery [ J ], Int J Pharm ,2004,278 ( 1 ) :71-77.
10MUller R H, Radtke M, Wissing S A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)in cosmetic and dermatological preparations [ J ]. Adv Drug Deliv Rev, 2002,54 : 131-155.
